Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

December 06, 2023 00:19:56
Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3
COR2ED - Oncology Medical Conversation
Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

Dec 06 2023 | 00:19:56

/

Show Notes

In this podcast episode, myeloma experts Dr. María Victoria Mateos (Haematologist at the University Hospital Salamanca, Spain) and Dr. Alexander Lesokhin (Associate Attending on the Myeloma Service at the Memorial Sloan Kettering Cancer Center, New York, NY, USA) discuss how they choose the best treatment regimen for patients with multiple myeloma and a high-risk cytogenetic profile. 

Firstly, they discuss the treatment options available for patients with high-risk cytogenetics in the US and in Europe. However, the key question is how to decide, for each individual, which treatment option is the best one. Dr. Mateos and Dr. Lesokhin discuss the factors they consider in these decisions in their clinical practice. Although the prior treatment is the most important consideration in the relapsed setting, the type of cytogenetic abnormality also plays a role. The experts specifically discuss treatment decisions in patients with extramedullary multiple myeloma: a difficult-to-treat population.

The speakers also discuss the future of myeloma treatment. How should trial design be adapted to better meet the needs of patients with a high-risk cytogenetic profile? What will be the role of CAR-T and bispecific antibodies in this population?

The experts conclude by summarising their key take-aways from the discussion.

Other Episodes

Episode

December 06, 2023 00:29:25
Episode Cover

Advanced HCC: 2nd line treatment and the right time to switch

Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium,...

Listen

Episode

December 06, 2023 00:24:43
Episode Cover

Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria...

Listen

Episode

December 06, 2023 00:29:56
Episode Cover

HCC: VEGFR-TKIs alone or in combination with immune checkpoint inhibitors

In this medical education podcast episode, Prof. Peter Galle and Prof. Amit Singal discuss the use of VEGFR-TKIs in the treatment of advanced or...

Listen